US
Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
HTRF mAb Anti-MBP Eu-Conjugate, 20,000 Assay Points
HTRF mAb Anti-MBP Eu-Conjugate, 20,000 Assay Points
MAb Anti MBP-Eu cryptate
Eu cryptate-labeled anti-MBP antibody for capturing MBP-tagged proteins in protein/protein interaction assays.
For research use only. Not for use in diagnostic procedures.
| Feature | Specification |
|---|---|
| Application | Protein-Protein Interaction |
Eu cryptate-labeled anti-MBP antibody for capturing MBP-tagged proteins in protein/protein interaction assays.
For research use only. Not for use in diagnostic procedures.
Product Variants
Unit Size: 5,000 Assay Points
Part #:
61MBPKAA
List Price
USD 609.47
Unit Size: 20,000 Assay Points
Part #:
61MBPKAB
List Price
USD 1,911.00
HTRF mAb Anti-MBP Eu-Conjugate, 20,000 Assay Points
MAb Anti MBP-Eu cryptate
HTRF mAb Anti-MBP Eu-Conjugate, 20,000 Assay Points
Product information
Overview
MAb Anti MBP-Eu cryptate is an IgG1 raised against a purified recombinant of Maltose Binding Protein (MBP) fusion protein labeled with Eu. It recognizes native as well as denatured-reduced forms of purified MBP or MBP fusion proteins.
This reagent can be used in both biochemical and cellular formats to study a wide variety of interactions: protein/protein, protein/peptide, protein/DNA, protein/RNA, protein/carbohydrate, protein/small molecule, receptor/ligand.
HTRF can detect a broad range of affinity constants ranging from picomolar to low millimolar.
Specifications
| Application |
Protein-Protein Interaction
|
|---|---|
| Brand |
HTRF
|
| Detection Modality |
HTRF
|
| Product Group |
Fluorescent Reagent
|
| Shipping Conditions |
Shipped in Dry Ice
|
| Target Class |
Binding Assay
|
| Technology |
TR-FRET
|
| Therapeutic Area |
Cardiovascular
Infectious Diseases
Inflammation
Metabolism/Diabetes
NASH/Fibrosis
Neuroscience
Oncology & Inflammation
Rare Diseases
|
| Unit Size |
20,000 Assay Points
|
Video gallery
HTRF mAb Anti-MBP Eu-Conjugate, 20,000 Assay Points
HTRF mAb Anti-MBP Eu-Conjugate, 20,000 Assay Points
How it works
Assay principle
In an HTRF interaction assay, one partner is labeled (directly or indirectly) with the donor, and the other with the acceptor (again, directly or indirectly). The intensity of the signal is proportional to the binding of the 2 partners. In the example shown here: MAb Anti MBP-Eu cryptate binds to the MBP tagged partner A while partner B* binds to a specific Ab labeled with an HTRF acceptor. *partner B can also be biotinylated, tagged, Fc fused. In these cases, use the corresponding HTRF reagent (anti-Tag, anti-species, protA, Streptavidin) labeled with acceptor for the detection.
Assay protocol
The example on the right describes the protocol using a 20 µL final assay volume for detecting an interaction between a MBP-tagged partner A and a non-tagged partner B*. Dispense the 2 partners (10 µL), incubate, add MAb Anti MBP-Eu cryptate (5 µL) and anti-partner B labeled with acceptor (5 µL), incubate and read. *partner B can also be biotinylated, tagged, Fc fused or directly labeled. In these cases, use the corresponding HTRF reagent (anti-Tag, anti species, protA, Streptavidin) labeled with acceptor for the detection.
Assay details
How do the number of tests relate to active moiety?
The average conjugate quantity per well reflects overall biological material content. Using the active moiety amount is generally preferred to the quantity of total conjugate. For Cryptate and d2 conjugates, the total conjugate amount equals that of the active moiety, since the molecular weight of the label is negligible. This is not the case for XL665 labeled entities for which the quantity of total conjugate will vary depending on the final molar ratio of the XL665 conjugate, however, the amount of active moiety, provided by Revvity, is constant and based on the number of tests ordered.
Recommended quantities of Cryptate and XL665 conjugates
Cryptate conjugates must not be excessive in order to prevent reader saturation and an unacceptable level of background. In most cases, a cryptate concentration of 1 to 5nM is appropriate, and will generate 20,000 to 80,000 cps at 620 nm depending on the HTRF compatible reader used. The XL665 conjugate must match its assay counterpart as closely as possible in order for the maximum number of biomolecules to be tagged with the XL665 acceptor. Thus, to detect a tagged molecule at an assay concentration of 20nM, the concentration of anti-Tag-XL665 should be equimolar or higher.
Resources
Are you looking for resources, click on the resource type to explore further.
Guide
HTRF solutions, guide to major applications
This guide provides you an overview of HTRF applications in several therapeutic areas.
How can we help you?
We are here to answer your questions.
